The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction

ABSTRACT Antimalarial drug resistance exacerbates the global disease burden and complicates eradication efforts. To facilitate the surveillance of resistance markers in countries of malaria endemicity, we developed a suite of TaqMan assays for known resistance markers and compartmentalized them into a single array card (TaqMan array card, TAC). We included 87 assays for species identification, for the detection of Plasmodium falciparum mutations associated with chloroquine, atovaquone, pyrimethamine, sulfadoxine, and artemisinin resistance, and for neutral single nucleotide polymorphism (SNP) genotyping. Assay performance was first optimized using DNA from common laboratory parasite lines and plasmid controls. The limit of detection was 0.1 to 10 pg of DNA and yielded 100% accuracy compared to sequencing. The tool was then evaluated on 87 clinical blood samples from around the world, and the malaria TAC once again achieved 100% accuracy compared to sequencing and in addition detected the presence of mixed infections in clinical samples. With its streamlined protocol and high accuracy, this malaria TAC should be a useful tool for large-scale antimalarial resistance surveillance.

[1]  D. Fidock,et al.  K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.

[2]  Shui-sen Zhou,et al.  A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment. , 2015, The Journal of infectious diseases.

[3]  Pardis C Sabeti,et al.  Rapid, Field-Deployable Method for Genotyping and Discovery of Single-Nucleotide Polymorphisms Associated with Drug Resistance in Plasmodium falciparum , 2012, Antimicrobial Agents and Chemotherapy.

[4]  Steve M. Taylor,et al.  Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. , 2015, The Journal of infectious diseases.

[5]  X. Su,et al.  Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. , 2012, The Lancet. Infectious diseases.

[6]  T. Wellems,et al.  Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt , pfmdr 1 and pfnhe 1 in Muheza , Tanzania , prior to introduction of artemisinin combination therapy Malaria Journal Sample , 2015 .

[7]  O. Stine,et al.  Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. , 2010, The Journal of infectious diseases.

[8]  S. Meshnick,et al.  Rapid Real-Time PCR Genotyping of Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum , 2004, Antimicrobial Agents and Chemotherapy.

[9]  Thomas A. Smith,et al.  The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea , 2008, Malaria Journal.

[10]  A. Nzila,et al.  Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites , 2000, Antimicrobial Agents and Chemotherapy.

[11]  C. Rogier,et al.  A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. , 2016, The New England journal of medicine.

[12]  G. Butcher,et al.  Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria , 2002, Malaria Journal.

[13]  N. Mishra,et al.  Surveillance of Artemisinin Resistance in Plasmodium falciparum in India Using the kelch13 Molecular Marker , 2015, Antimicrobial Agents and Chemotherapy.

[14]  I. Mueller,et al.  A Multiplex Ligase Detection Reaction-Fluorescent Microsphere Assay for Simultaneous Detection of Single Nucleotide Polymorphisms Associated with Plasmodium falciparum Drug Resistance , 2006, Journal of Clinical Microbiology.

[15]  Samuel A. Assefa,et al.  Drug-Resistant Genotypes and Multi-Clonality in Plasmodium falciparum Analysed by Direct Genome Sequencing from Peripheral Blood of Malaria Patients , 2011, PloS one.

[16]  Jian Li,et al.  High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko island, Equatorial Guinea , 2014, Pathogens and global health.

[17]  Jutta Marfurt,et al.  Rapid Microarray-Based Method for Monitoring of All Currently Known Single-Nucleotide Polymorphisms Associated with Parasite Resistance to Antimalaria Drugs , 2007, Journal of Clinical Microbiology.

[18]  Yilong Zhang,et al.  Distinctive Origin and Spread Route of Pyrimethamine-Resistant Plasmodium falciparum in Southern China , 2013, Antimicrobial Agents and Chemotherapy.

[19]  J. Barnwell,et al.  Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign , 2015, PLoS pathogens.

[20]  Adele M. Lehane,et al.  Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies , 2016, Nature Communications.

[21]  Steve M. Taylor,et al.  Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women , 2010, Malaria Journal.

[22]  X. Su,et al.  Genome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in Plasmodium falciparum from China-Myanmar border , 2016, Scientific Reports.

[23]  P. Phillips-Howard,et al.  The epidemiology of drug-resistant malaria. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  J. Dumler,et al.  Multiplex 5′ Nuclease Quantitative Real-Time PCR for Clinical Diagnosis of Malaria and Species-Level Identification and Epidemiologic Evaluation of Malaria-Causing Parasites, Including Plasmodium knowlesi , 2013, Journal of Clinical Microbiology.

[25]  P. Siba,et al.  Molecular Assessment of Plasmodium falciparum Resistance to Antimalarial Drugs in Papua New Guinea Using an Extended Ligase Detection Reaction Fluorescent Microsphere Assay , 2010, Antimicrobial Agents and Chemotherapy.

[26]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[27]  S. Meshnick,et al.  A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR , 2004, Malaria Journal.

[28]  F. Seeber.  Faculty Opinions recommendation of Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. , 2016 .

[29]  S. Thammapalo,et al.  Distribution of pfmdr1 polymorphisms in Plasmodium falciparum isolated from Southern Thailand , 2014, Malaria Journal.

[30]  M. Armstrong,et al.  Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. , 2007, The Journal of antimicrobial chemotherapy.

[31]  J. Baeten,et al.  The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study* , 2012, Critical care medicine.

[32]  C. Ockenhouse,et al.  Development of a TaqMan Allelic Discrimination Assay for detection of Single Nucleotides Polymorphisms associated with anti-malarial drug resistance , 2012, Malaria Journal.

[33]  H. Babiker,et al.  High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. , 2001, The Journal of infectious diseases.

[34]  L. Cui,et al.  Artemisinin Resistance at the China-Myanmar Border and Association with Mutations in the K13 Propeller Gene , 2015, Antimicrobial Agents and Chemotherapy.

[35]  E. Houpt,et al.  Development of a TaqMan Array Card for Pneumococcal Serotyping on Isolates and Nasopharyngeal Samples , 2016, Journal of Clinical Microbiology.

[36]  J. Crump,et al.  Development of a TaqMan Array Card for Acute-Febrile-Illness Outbreak Investigation and Surveillance of Emerging Pathogens, Including Ebola Virus , 2015, Journal of Clinical Microbiology.

[37]  J. Farrar,et al.  In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam , 2012, Malaria Journal.

[38]  I. González,et al.  Loop Mediated Isothermal Amplification (LAMP) Accurately Detects Malaria DNA from Filter Paper Blood Samples of Low Density Parasitaemias , 2014, PloS one.

[39]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[40]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[41]  R. Maude,et al.  Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker , 2015, The Lancet. Infectious diseases.

[42]  S. Meshnick,et al.  Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. , 2005, Acta tropica.

[43]  C. Plowe.  Monitoring antimalarial drug resistance: making the most of the tools at hand , 2003, Journal of Experimental Biology.

[44]  Shihab U. Sobuz,et al.  A Laboratory-Developed TaqMan Array Card for Simultaneous Detection of 19 Enteropathogens , 2012, Journal of Clinical Microbiology.

[45]  Jonathan J. Juliano,et al.  High-Throughput Pooling and Real-Time PCR-Based Strategy for Malaria Detection , 2009, Journal of Clinical Microbiology.

[46]  O. Doumbo,et al.  Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. , 2004, The Journal of infectious diseases.

[47]  Samuel A. Assefa,et al.  Whole-Genome Scans Provide Evidence of Adaptive Evolution in Malawian Plasmodium falciparum Isolates , 2014, The Journal of infectious diseases.

[48]  V. do Rosário,et al.  Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand , 2002, Malaria Journal.

[49]  Shui-sen Zhou,et al.  Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China , 2012, Malaria Journal.

[50]  J. Perin,et al.  Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar , 2013, PloS one.

[51]  Pardis C Sabeti,et al.  A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking , 2008 .

[52]  Jennifer L. Guler,et al.  Asexual Populations of the Human Malaria Parasite, Plasmodium falciparum, Use a Two-Step Genomic Strategy to Acquire Accurate, Beneficial DNA Amplifications , 2013, PLoS pathogens.

[53]  Jean Gratz,et al.  Integrated Microfluidic Card with TaqMan Probes and High-Resolution Melt Analysis To Detect Tuberculosis Drug Resistance Mutations across 10 Genes , 2015, mBio.

[54]  P. Chiodini,et al.  Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil , 2008, Malaria Journal.

[55]  J. Barnwell,et al.  Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria , 2014, Open forum infectious diseases.

[56]  J. Kampeera,et al.  Simple detection of single nucleotide polymorphism in Plasmodium falciparum by SNP-LAMP assay combined with lateral flow dipstick. , 2017, Parasitology international.